BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 24517558)

  • 1. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
    Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Kotani T; Takeuchi T; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Makino S; Hanafusa T
    Lupus; 2006; 15(10):683-5. PubMed ID: 17120596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome.
    Takahashi N; Naniwa T; Banno S
    Mod Rheumatol; 2008; 18(1):72-5. PubMed ID: 18161002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review.
    Ueda Y; Yamashita H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Clin Rheumatol; 2014 Feb; 33(2):281-6. PubMed ID: 24343456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus.
    Kamiya K; Kurasawa K; Arai S; Maezawa R; Hanaoka R; Kumano K; Fukuda T
    Mod Rheumatol; 2010 Feb; 20(1):81-5. PubMed ID: 19784542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M; Silverman ED; Levy DM
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
    Pottier V; Pierrot M; Subra JF; Mercat A; Kouatchet A; Parrot A; Augusto JF
    Lupus; 2011 May; 20(6):656-9. PubMed ID: 21335399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
    Abdwani R; Mani R
    Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in steroid refractory autoimmune hemolytic anemia.
    Gupta N; Sharma S; Seth T; Mishra P; Mahapatra M; Kumar S; Kapoor R; Agarwal N
    Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
    Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
    Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
    Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
    Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
    Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus.
    Pavo-Blanco M; Novella-Navarro M; Cáliz-Cáliz R; Ferrer-González MA
    Reumatol Clin (Engl Ed); 2018; 14(4):248-249. PubMed ID: 28870533
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab in the treatment of bullous systemic lupus erythematosus.
    Alsanafi S; Kovarik C; Mermelstein AL; Werth VP
    J Clin Rheumatol; 2011 Apr; 17(3):142-4. PubMed ID: 21441817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis.
    Henzan T; Nagafuji K; Tsukamoto H; Miyamoto T; Gondo H; Imashuku S; Harada M
    Am J Hematol; 2006 Jan; 81(1):59-61. PubMed ID: 16369976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
    Gonzalez-Nieto JA; Martin-Suarez I; Quattrino S; Ortiz-Lopez E; Muñoz-Beamud FR; Colchero-Fernández J; Alcoucer-Diaz MR
    Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A: a case report.
    Wang SW; Cheng TT
    Lupus; 2005; 14(6):483-5. PubMed ID: 16038113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy.
    Tsai MJ; Chou CW; Lin FC; Chang SC
    Lupus; 2012 Jul; 21(8):914-8. PubMed ID: 22287506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus.
    Keith MP; Pitchford C; Bernstein WB
    J Clin Rheumatol; 2012 Apr; 18(3):134-7. PubMed ID: 22426581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.